{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:14:15Z","timestamp":1784546055617,"version":"3.55.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MPs"],"abstract":"<jats:p>Intravenous medications are frequently administered through shared catheter lines in neonatal intensive care units (NICUs) due to the limited venous access in preterm infants, raising concerns about drug incompatibilities that may cause serious complications. Hydrocortisone sodium (HDC), ampicillin (ABPC), and cefotaxime (CTX) are commonly used in NICUs and are often co-administered with unfractionated heparin (UFH), which is routinely infused to prevent catheter occlusion. This study evaluated the physicochemical compatibility of HDC, ABPC, and CTX when mixed with UFH. Each drug was combined with UFH at equal volumes, and the mixtures were assessed immediately and after 3 h of storage by visual inspection, pH measurement, UV absorbance, and HPLC-UV analysis. No precipitation, turbidity, or color changes were observed in any mixture, and UV absorbance showed no relevant deviations compared with controls. Slight pH variations were detected but remained within acceptable limits. In semi-quantitative HPLC analysis, relative peak area changes were all below 10%, indicating no major degradation of the drugs. These findings suggest that HDC, ABPC, and CTX maintain acceptable physicochemical compatibility when co-administered with UFH, supporting their safe concomitant use in NICU practice.<\/jats:p>","DOI":"10.3390\/mps8060136","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:51:43Z","timestamp":1762451503000},"page":"136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Compatibility Investigation of a Steroid and Two Antibiotics with Heparin for the Prevention of Catheter Occlusion in Neonatal Intensive Care Units"],"prefix":"10.3390","volume":"8","author":[{"given":"Mao","family":"Maekawa","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-0298","authenticated-orcid":false,"given":"Masamitsu","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-2408","authenticated-orcid":false,"given":"Yu","family":"Sato","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 983-8536, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-6355","authenticated-orcid":false,"given":"Shimpei","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Center for Perinatal and Neonatal Medicine, Tohoku University Hospital, Sendai 980-8572, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Center for Perinatal and Neonatal Medicine, Tohoku University Hospital, Sendai 980-8572, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ejhpharm-2019-001939","article-title":"Intravenous drug use in neonatal intensive care units","volume":"28","author":"Mendiola","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00431-021-04028-9","article-title":"Drug compatibility in neonatal intensive care units: Gaps in knowledge and discordances","volume":"180","author":"Katsumiti","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-0105.134984","article-title":"A clinical study on drug-related problems associated with intravenous drug administration","volume":"5","author":"Vijayakumar","year":"2014","journal-title":"J. Basic. Clin. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Leopoldino, R.W., Costa, H.T., Costa, T.X., Martins, R.R., and Oliveira, A.G. (2018). Potential drug incompatibilities in the neonatal intensive care unit: A network analysis approach. BMC Pharmacol. Toxicol., 19.","DOI":"10.1186\/s40360-018-0265-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/014860719602000181","article-title":"Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution","volume":"20","author":"Hill","year":"1996","journal-title":"J. Parenter. Enteral Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1234","DOI":"10.1542\/peds.2008-3080","article-title":"Intravenous ceftriaxone and calcium in the neonate: Assessing the risk for cardiopulmonary adverse events","volume":"123","author":"Bradley","year":"2009","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2009.174268","article-title":"Compatibility of drug infusions in the NICU","volume":"95","author":"Kalikstad","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.2018.21443","article-title":"Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation","volume":"321","author":"Onland","year":"2019","journal-title":"JAMA"},{"key":"ref_9","first-page":"CD012345","article-title":"Late (\u22657 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): A double-blind, placebo-controlled, multicentre, randomised trial","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000098168","article-title":"Early low-dose hydrocortisone in very preterm infants: A randomized, placebo-controlled trial","volume":"91","author":"Bonsante","year":"2007","journal-title":"Neonatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1542\/peds.2004-1159","article-title":"Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: A multicenter trial","volume":"114","author":"Watterberg","year":"2004","journal-title":"Pediatrics"},{"key":"ref_13","unstructured":"Pfizer Japan Inc (2024). Solu-Cortef\u00ae Injection 100 mg Interview Form, Pfizer Japan Inc.. [17th ed.]."},{"key":"ref_14","first-page":"CD002772","article-title":"Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters","volume":"2","author":"Shah","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1542\/peds.2006-0529","article-title":"A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: The HIP (Heparin Infusion for PCVC) study","volume":"119","author":"Shah","year":"2007","journal-title":"Pediatrics"},{"key":"ref_16","first-page":"692","article-title":"Heparinization of long indwelling lines in neonates: Systematic review and practical recommendations","volume":"18","author":"Wasserteil","year":"2016","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_17","first-page":"522","article-title":"Intravenous physical compatibility of heparin sodium and furosemide","volume":"26","author":"Maktabi","year":"2022","journal-title":"Int. J. Pharm. Compd."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajhp\/zxac306","article-title":"Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration","volume":"80","author":"Kenneally","year":"2023","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jac\/dki311","article-title":"Stability of heparin and physical compatibility of heparin\/antibiotic solutions in concentrations appropriate for antibiotic lock therapy","volume":"56","author":"Robinson","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/8755122520924767","article-title":"The physical compatibility of clinically used concentrations of diltiazem hydrochloride with heparin sodium","volume":"36","author":"Dobson","year":"2020","journal-title":"J. Pharm. Technol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2146\/ajhp110715","article-title":"Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration","volume":"70","author":"Fox","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_22","first-page":"63","article-title":"The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration","volume":"15","author":"Semark","year":"2013","journal-title":"Crit. Care Resusc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ajhp\/zxaa118","article-title":"Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients","volume":"77","author":"Foushee","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_24","unstructured":"Mochida Pharmaceutical Co (2024). Heparin Sodium Injection 5000 Units\/5 mL; Heparin Sodium Injection 10,000 Units\/10 mL Interview Form, Mochida Pharmaceutical Co.. [8th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.inf.0000178064.55193.1c","article-title":"Use of antimicrobial agents in United States neonatal and pediatric intensive care patients","volume":"24","author":"Grohskopf","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/INF.0000000000000542","article-title":"Prospective surveillance of antibiotic use in the neonatal intensive care unit","volume":"34","author":"Cantey","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13643-019-1207-1","article-title":"Antibiotic regimens for neonatal sepsis\u2014A protocol for a systematic review with meta-analysis","volume":"8","author":"Korang","year":"2019","journal-title":"Syst. Rev."},{"key":"ref_28","first-page":"CD013837","article-title":"Antibiotic regimens for early-onset neonatal sepsis","volume":"5","author":"Korang","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Thampi, N., Shah, P.S., Nelson, S., Agarwal, A., Steinberg, M., Diambomba, Y., and Morris, A.M. (2019). Prospective audit and feedback on antibiotic use in neonatal intensive care: A retrospective cohort study. BMC Pediatr., 19.","DOI":"10.1186\/s12887-019-1481-z"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"F141","DOI":"10.1136\/adc.2007.120709","article-title":"Improving antibiotic prescribing in neonatal units: Time to act","volume":"97","author":"Russell","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/712150","article-title":"Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis","volume":"2011","author":"Sivanandan","year":"2011","journal-title":"Int. J. Pediatr."},{"key":"ref_32","first-page":"238","article-title":"Physical compatibility of medications used in critically ill patients with balanced fluid solutions","volume":"24","author":"Wilder","year":"2020","journal-title":"Int. J. Pharm. Compd."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2022.06.006","article-title":"Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs","volume":"275","author":"Bautista","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12519-022-00610-9","article-title":"Assessment of compatibility of rhIGF-1\/rhIGFBP-3 with neonatal intravenous medications","volume":"19","author":"Turner","year":"2023","journal-title":"World J. Pediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0886-3350(97)80247-7","article-title":"Compatibility of corticosteroids and antibiotics in combination","volume":"23","author":"Mahlberg","year":"1997","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00431-022-04466-z","article-title":"Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit\u2014Physical compatibility between three components","volume":"181","author":"Nilsson","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_37","first-page":"346","article-title":"Compatibility and stability of cefotaxime, vancomycin, and ciprofloxacin in antibiotic lock solutions containing heparin","volume":"14","author":"Baker","year":"2010","journal-title":"Int. J. Pharm. Compd."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2146\/ajhp090505","article-title":"Physical compatibility of 4% sodium citrate with selected antimicrobial agents","volume":"67","author":"Dotson","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpb.2020.04.008","article-title":"Supporting the use of sildenafil infusions in paediatric and neonatal intensive care\u2014A compatibility study","volume":"151","author":"AlSalman","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SHK.0000000000001316","article-title":"Comparison between continuous and intermittent administration of hydrocortisone during septic shock: A randomized controlled clinical trial","volume":"52","author":"Tilouche","year":"2019","journal-title":"Shock"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/aer.aer_115_22","article-title":"Hyperglycemia risk evaluation of hydrocortisone intermittent boluses versus continuous infusion in septic shock: A prospective randomized trial","volume":"16","author":"Ram","year":"2022","journal-title":"Anesth. Essays Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1051-0443(97)70611-0","article-title":"Flow characteristics of peripherally inserted central catheters","volume":"8","author":"Angle","year":"1997","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2016.07.019","article-title":"Dosing errors in preterm neonates due to flow rate variability in multi-infusion syringe pump setups: An in vitro spectrophotometry study","volume":"93","author":"Snijder","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Watrobska-Swietlikowska, D. (2019). Compatibility of maximum inorganic and organic calcium and phosphate content in neonatal parenteral solutions. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-46987-y"}],"container-title":["Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-9279\/8\/6\/136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:25:15Z","timestamp":1762579515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-9279\/8\/6\/136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["mps8060136"],"URL":"https:\/\/doi.org\/10.3390\/mps8060136","relation":{},"ISSN":["2409-9279"],"issn-type":[{"value":"2409-9279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}